Dietary Aspects and Drug-Related Side Effects in Autosomal Dominant Polycystic Kidney Disease Progression.

Author: QuirogaBorja, TorraRoser

Paper Details 
Original Abstract of the Article :
Autosomal dominant polycystic kidney disease (ADPKD) is the most commonly inherited kidney disease. In the absence of targeted therapies, it invariably progresses to advanced chronic kidney disease. To date, the only approved treatment is tolvaptan, a vasopressin V2 receptor antagonist that has been...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658114/

データ提供:米国国立医学図書館(NLM)

The Quest for Effective Therapies for Autosomal Dominant Polycystic Kidney Disease

Autosomal dominant polycystic kidney disease (ADPKD), a debilitating genetic disorder, represents a significant challenge in the field of nephrology. This research explores the current landscape of ADPKD management, focusing on the role of dietary modifications and the impact of tolvaptan, the only FDA-approved treatment for this condition. The study aims to provide a comprehensive overview of dietary aspects and drug-related side effects in the progression of ADPKD, highlighting the importance of multi-faceted treatment approaches.

Managing ADPKD: A Balancing Act of Diet and Medications

The study emphasizes the role of dietary modifications, such as moderate sodium restriction, moderate protein intake, and increased water consumption, in mitigating ADPKD progression. While tolvaptan has shown promise in reducing cyst growth, its aquaretic side effects, which lead to frequent urination, pose a significant challenge. The study explores strategies to combat these side effects, including the use of thiazides, metformin, and adjustments in dietary osmotic load.

Living with ADPKD: A Path Towards Healthier Living

This research underscores the importance of a holistic approach to managing ADPKD. By combining dietary modifications with appropriate medical therapies, individuals with ADPKD can strive to slow disease progression and improve their quality of life. This research serves as a valuable resource for patients and clinicians alike, highlighting the potential of personalized management strategies in optimizing outcomes for individuals with this challenging condition.

Dr. Camel's Conclusion

The journey with ADPKD is a long and arduous one, but this research offers valuable insights into the tools available for managing this complex condition. By combining dietary modifications with appropriate medical therapies, individuals with ADPKD can navigate their journey with increased knowledge and a renewed sense of hope.

Date :
  1. Date Completed 2022-11-14
  2. Date Revised 2022-11-17
Further Info :

Pubmed ID

36364911

DOI: Digital Object Identifier

PMC9658114

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.